XML 71 R36.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Employee Benefits and Stock Compensation (Tables)
12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation
The impact of share-based compensation on the Company’s financial results is presented below:
 
 
For the Year Ended December 31,
(In thousands)
 
2019
 
2018
 
2017
Share-based compensation expense
 
$
7,244

 
$
7,823

 
5,267

Income tax benefit
 
(1,723
)
 
(1,911
)
 
(1,966
)

Schedule of Unrecognized Compensation Cost, Nonvested Awards
The total unrecognized compensation cost and the weighted-average period over which unrecognized compensation cost is expected to be recognized related to non-vested share-based compensation arrangements at December 31, 2019 is presented below:
(In thousands)
 
Unrecognized
Compensation
Cost
 
Weighted-Average Period Remaining (Years)
Restricted stock awards
 
$
3,577

 
1.6
Restricted stock units
 
3,921

 
1.7
Stock options
 
697

 
0.9
Total
 
$
8,195

 
1.6

Schedule of Nonvested Share Activity
A summary of the status of the Company’s non-vested RSAs as of December 31, 2019, and changes during the year then ended, is presented below:
 
 
Restricted
Award
Shares
 
Weighted-Average Grant-Date Fair Value
Non-vested at January 1, 2019
 
295,130

 
$
24.09

Granted
 
157,861

 
26.86

Forfeited/Canceled
 
(63,666
)
 
25.83

Vested
 
(175,374
)
 
23.54

Non-vested at December 31, 2019
 
213,951

 
26.07


A summary of the status of the Company’s non-vested RSUs as of December 31, 2019, and changes during the year then ended, is presented below:
 
 
Restricted
Award
Shares
 
Weighted-Average Grant-Date Fair Value
Non-vested at January 1, 2019
 
503,111

 
$
19.69

Granted
 
75,002

 
30.02

Forfeited/Canceled
 
(8,242
)
 
20.29

Vested
 
(187,941
)
 
15.24

Non-vested at December 31, 2019
 
381,930

 
23.89


Schedule of Restricted Stock and Restricted Stock Units Activity
Information regarding restricted stock awards during each of the following years is presented below:
 
 
Year Ended December 31,
 
 
2019
 
2018
 
2017
Shares granted
 
157,861

 
242,613

 
114,331

Weighted-average grant date fair value
 
$
26.86

 
$
26.48

 
$
24.08

Fair value of awards vested1
 
$
4,128

 
$
2,515

 
$
1,407

1Based on grant date fair value, in thousands

Information regarding restricted stock units during each of the following years:
 
 
For the Year Ended December 31,
 
 
2019
 
2018
 
2017
Shares granted
 
75,002

 
173,193

 
164,268

Weighted-average grant date fair value
 
$
30.02

 
$
24.02

 
$
23.94

Fair value of awards vested1
 
$
2,864

 
$
1,095

 
$
937

1Based on grant date fair value

Schedule of Stock Option Valuation Assumptions
The Company estimated the fair value of each option grant on the date of grant using the Black-Scholes options-pricing model with the following weighted-average assumptions:    
 
 
For the Year Ended December 31,
 
 
2019
 
2018
 
2017
Risk-free interest rates
 
2.53
%
 
2.56
%
 
1.85
%
Expected dividend yield
 
%
 
%
 
%
Expected volatility
 
34.5
%
 
26.6
%
 
25.4
%
Expected lives (years)
 
5.0

 
5.0

 
5.0


Schedule of Stock Options Roll Forward
A summary of the Company’s stock options as of December 31, 2019, and changes during the year then ended, are presented below:
 
 
Options
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Term (Years)
 
Aggregate
Intrinsic
Value
(000s)
Outstanding at January 1, 2019
 
933,495

 
$
22.00

 
 
 
 
Granted
 
3,438

 
28.42

 
 
 
 
Exercised
 
(28,824
)
 
14.86

 
 
 
 
Forfeited
 
(4,330
)
 
29.17

 
 
 
 
Outstanding at December 31, 2019
 
903,779

 
22.22

 
6.14
 
$
7,669

Exercisable at December 31, 2019
 
633,561

 
19.82

 
5.65
 
6,848


Schedule of Stock Option Activity nformation related to stock options during each of the following years:
 
 
For the Year Ended December 31,
 
 
2019
 
2018
 
2017
Options granted
 
3,438

 
219,118

 
297,576

Weighted-average grant date fair value
 
$
28.42

 
$
5.65

 
$
4.66

Intrinsic value of stock options exercised
 
277

 
3,045

 
1,143


Schedule of Options Outstanding and Remaining Contractual Life of Stock Options
The following table summarizes information related to stock options as of December 31, 2019
Range of Exercise Prices
 
Options
Outstanding
 
Remaining
Contractual
Life (Years)
 
Options
Exercisable
 
Weighted
Average
Exercise
Price
$10.54 to $14.82
 
368,611

 
4.2
 
334,016

 
$
12.42

$15.99 to $28.69
 
326,909

 
7.1
 
229,824

 
27.16

$31.15 to $31.15
 
208,259

 
8.2
 
69,721

 
31.15

Total
 
903,779

 
6.1
 
633,561

 
$
19.82


Schedule of Employee Stock Purchase Plan Activity Employee contributions to the ESPP are made through payroll deductions. 
 
 
2019
 
2018
 
2017
ESPP shares purchased
 
16,320

 
15,225

 
12,434

Weighted-average employee purchase price
 
$
25.39

 
$
26.85

 
$
22.67